November 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 26, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJanuary 08, 2026
Based on market forecasts, the DNA polymerase sector will expand from USD 419.87 million in 2025 to USD 769.12 million by 2035, experiencing a CAGR of 6.24%.The DNA polymerase market is expanding due to growing demand for diagnostic applications as well as advancements in PCR techniques. North America led the market due to the presence of an advanc...
January 08, 2026
Projections indicate that, the global gene prediction tools market will increase from USD 237.44 million in 2025 to USD 1320.67 million by 2035, experiencing a CAGR of 18.72% over the next 10 years. Currently, the respective market is driven by the accelerating demand for personalized treatments in different conditions and the reduction in expendit...
January 08, 2026
Market insights predict, the proteinase K industry is expected to grow from USD 5.23 billion in 2025 to USD 11.87 billion by 2035, driven by a CAGR of 8.54%. The rising prevalence of infectious and other chronic disorders and the growing demand for early diagnosis drive the market. North America led the global market owing to the presence of state-...
January 08, 2026
Projections indicate that, metagenomics industry is projected to rise from USD 2.68 billion in 2025 to USD 9.55 billion by 2035, reflecting a CAGR of 13.55% over the next decade. The metagenomics market is expanding due to the growing incidence of infectious diseases as well as rising advancements in metagenomics. North America led the market due t...
January 07, 2026
Based on market forecasts, the western blotting sector will expand from USD 2.13 billion in 2025 to USD 3.84 billion by 2035, experiencing a CAGR of 6.05%. The increasing prevalence of chronic disorders and technological advancements drive the market. North America dominated the global market owing to the presence of key players and increasing rese...
January 07, 2026
The growing genomics research and technological advancements drive the market. North America dominated the global market owing to state-of-the-art research and development facilities and the presence of key players....
January 07, 2026
Market insights predict the global small scale bioreactors industry will increase from USD 2.63 billion in 2025 to USD 10.49 billion by 2035, achieving a CAGR of 14.84%. The growing demand for biopharmaceuticals and technological advancements drives the market. North America led the global market due to the presence of key players and favorable gov...
January 06, 2026
Market insights predict, the U.S. next generation sequencing industry is expected to grow from USD 2.85 billion in 2025 to USD 12.52 billion by 2035, driven by a CAGR of 15.95%. The growing demand for personalized medicines and the increasing adoption of advanced technologies drive the market....
January 06, 2026
According to market projections, the global biostimulants market, valued at USD 3.29 billion in 2025, is anticipated to reach USD 6.74 billion by 2035, growing at a CAGR of 7.44% over the next decade. Biostimulants are eco-friendly tools that boost plant growth, yield, and stress resistance. In 2024, Europe led the market, while Asia Pacific is set...
January 06, 2026
According to market projections, the liquid biopsy sector is expected to grow from USD 7.08 billion in 2025 to USD 27.42 billion by 2035, reflecting a CAGR of 14.5%, driven by the need for non-invasive cancer diagnostics. It enables real-time monitoring, early detection, and personalized treatment. Advances in NGS, ctDNA analysis, and AI are enhanc...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com